No Data
Black Book Ranks Veradigm Payer Analytics the #1 Overall Payer Analytics Solutions Vendor in 2024
Veradigm(OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that Black Book Research, a healthcare-centric market research and public opinion research and consulting company, rated Veradigm Payer Analytics the overall number one provider of payer analytics solutions for health plans.
Veradigm Payerpath Rated Highest in Client Satisfaction
For the third consecutive year, the comprehensive set of solutions has been rated the overall #1 provider for small physician practice clearinghouse servicesCHICAGO--(BUSINESS WIRE)--Veradigm(OTCMKTS:
Veradigm Is Maintained at Buy by TD Cowen
Veradigm Is Maintained at Buy by TD Cowen
TD Cowen Maintains Buy on Veradigm, Lowers Price Target to $15
TD Cowen analyst Charles Rhyee maintains Veradigm with a Buy and lowers the price target from $26 to $15.
Veradigm Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/28/2024 81.49% TD Cowen $26 → $15 Maintains Buy 03/19/2024 21% Deutsche Bank $15 → $10 Downgrades Buy →
Veradigm — does not intend to appoint any long-term executives while separately announcing that it is exploring strategic alternatives
Veradigm — does not intend to appoint any long-term executives while separately announcing that it is exploring strategic alternatives